# cbdMD, Inc.: financial statements, quarterly YCBD · NYSE · CIK 1644903 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/ycbd.md) · [Financials](/companies/ycbd/financials.md) · [Filings](/companies/ycbd/filings.md) · [Insiders](/companies/ycbd/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ycbd/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [5.7 d](/filings/0001437749-24-037840.md) | [5.4](/filings/0001437749-25-003752.md) | [4.4](/filings/0001437749-25-017178.md) | [5.2](/filings/0001437749-25-026930.md) | [4.6 d](/filings/0001437749-25-038435.md) | [5.1](/filings/0001437749-26-004343.md) | [4.7](/filings/0001437749-26-017042.md) | [4.6](/filings/0001437749-26-027665.md) | [4.7 d](/filings/0001437749-25-038435.md) | [5.0](/filings/0001437749-26-004343.md) | [5.6](/filings/0001437749-26-017042.md) | [5.6](/filings/0001437749-26-027665.md) | | Cost of revenue | $m | [2.2 d](/filings/0001437749-24-037840.md) | [1.8](/filings/0001437749-25-003752.md) | [1.8](/filings/0001437749-25-017178.md) | [1.8](/filings/0001437749-25-026930.md) | [2.1 d](/filings/0001437749-25-038435.md) | [1.7](/filings/0001437749-26-004343.md) | [1.8](/filings/0001437749-26-017042.md) | [1.8](/filings/0001437749-26-027665.md) | [1.9 d](/filings/0001437749-25-038435.md) | [2.0](/filings/0001437749-26-004343.md) | [2.4](/filings/0001437749-26-017042.md) | [2.5](/filings/0001437749-26-027665.md) | | Gross profit | $m | [3.5 d](/filings/0001437749-24-037840.md) | [3.6](/filings/0001437749-25-003752.md) | [2.6](/filings/0001437749-25-017178.md) | [3.4](/filings/0001437749-25-026930.md) | [2.5 d](/filings/0001437749-25-038435.md) | [3.4](/filings/0001437749-26-004343.md) | [3.0](/filings/0001437749-26-017042.md) | [2.8](/filings/0001437749-26-027665.md) | [2.8 d](/filings/0001437749-25-038435.md) | [3.0](/filings/0001437749-26-004343.md) | [3.3](/filings/0001437749-26-017042.md) | [3.0](/filings/0001437749-26-027665.md) | | Operating income | $m | [(15.2) d](/filings/0001437749-24-037840.md) | [(1.1)](/filings/0001437749-25-003752.md) | [(1.6)](/filings/0001437749-25-017178.md) | [(0.4)](/filings/0001437749-25-026930.md) | [(0.3) d](/filings/0001437749-25-038435.md) | [(0.1)](/filings/0001437749-26-004343.md) | [(0.5)](/filings/0001437749-26-017042.md) | [(0.9)](/filings/0001437749-26-027665.md) | [(0.7) d](/filings/0001437749-25-038435.md) | [(0.3)](/filings/0001437749-26-004343.md) | [(0.8)](/filings/0001437749-26-017042.md) | [(1.1)](/filings/0001437749-26-027665.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [0.0 d](/filings/0001437749-24-037840.md) | [0.0](/filings/0001437749-24-003902.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net income | $m | [(15.9)](/filings/0001437749-24-037840.md) | [(1.0)](/filings/0001437749-25-026930.md) | [(3.0)](/filings/0001437749-25-026930.md) | [0.5](/filings/0001437749-25-026930.md) | [(0.2)](/filings/0001437749-24-037840.md) | [0.0](/filings/0001437749-26-004343.md) | [(0.5)](/filings/0001437749-26-017042.md) | [(0.9)](/filings/0001437749-26-027665.md) | [(0.7) d](/filings/0001437749-25-038435.md) | [(0.3)](/filings/0001437749-26-004343.md) | [(0.8)](/filings/0001437749-26-017042.md) | [(1.1)](/filings/0001437749-26-027665.md) | | Diluted EPS | $ per share | not reported | not reported | [(1.35)](/filings/0001437749-24-017042.md) | [(0.15)](/filings/0001437749-24-026784.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Basic EPS | $ per share | not reported | [(0.67)](/filings/0001437749-25-003752.md) | [(10.84)](/filings/0001437749-25-017178.md) | [(8.93)](/filings/0001437749-25-026930.md) | not reported | [(1.73)](/filings/0001437749-26-004343.md) | [(1.90)](/filings/0001437749-26-017042.md) | [(0.21)](/filings/0001437749-26-027665.md) | not reported | [(0.04)](/filings/0001437749-26-004343.md) | [(0.08)](/filings/0001437749-26-017042.md) | [(0.11)](/filings/0001437749-26-027665.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [1.8](/filings/0001437749-24-037840.md) | [1.5](/filings/0001437749-24-003902.md) | [2.1](/filings/0001437749-24-017042.md) | [2.4](/filings/0001437749-24-026784.md) | [2.5](/filings/0001437749-25-038435.md) | [2.0](/filings/0001437749-25-003752.md) | [1.8](/filings/0001437749-25-017178.md) | [1.1](/filings/0001437749-25-026930.md) | [2.3](/filings/0001437749-26-027665.md) | [3.4](/filings/0001437749-26-004343.md) | [2.6](/filings/0001437749-26-017042.md) | [2.1](/filings/0001437749-26-027665.md) | | Current assets | $m | [8.1](/filings/0001437749-24-037840.md) | [7.4](/filings/0001437749-24-003902.md) | [7.4](/filings/0001437749-24-017042.md) | [7.3](/filings/0001437749-24-026784.md) | [6.4](/filings/0001437749-25-038435.md) | [6.4](/filings/0001437749-25-003752.md) | [6.2](/filings/0001437749-25-017178.md) | [5.6](/filings/0001437749-25-026930.md) | [6.6](/filings/0001437749-26-027665.md) | [8.2](/filings/0001437749-26-004343.md) | [8.4](/filings/0001437749-26-017042.md) | [7.7](/filings/0001437749-26-027665.md) | | Total assets | $m | [16.2](/filings/0001437749-24-037840.md) | [15.1](/filings/0001437749-24-003902.md) | [14.6](/filings/0001437749-24-017042.md) | [13.8](/filings/0001437749-24-026784.md) | [10.6](/filings/0001437749-25-038435.md) | [11.5](/filings/0001437749-25-003752.md) | [10.9](/filings/0001437749-25-017178.md) | [9.9](/filings/0001437749-25-026930.md) | [10.4](/filings/0001437749-26-027665.md) | [11.8](/filings/0001437749-26-004343.md) | [12.3](/filings/0001437749-26-017042.md) | [13.1](/filings/0001437749-26-027665.md) | | Current liabilities | $m | [4.7](/filings/0001437749-24-037840.md) | [6.0](/filings/0001437749-24-003902.md) | [6.9](/filings/0001437749-24-017042.md) | [7.9](/filings/0001437749-24-026784.md) | [8.6](/filings/0001437749-25-038435.md) | [9.2](/filings/0001437749-25-003752.md) | [9.9](/filings/0001437749-25-017178.md) | [3.6](/filings/0001437749-25-026930.md) | [3.2](/filings/0001437749-26-027665.md) | [2.8](/filings/0001437749-26-004343.md) | [3.0](/filings/0001437749-26-017042.md) | [3.1](/filings/0001437749-26-027665.md) | | Total liabilities | $m | [7.2](/filings/0001437749-24-037840.md) | [8.1](/filings/0001437749-24-003902.md) | [11.5](/filings/0001437749-24-017042.md) | [10.8](/filings/0001437749-24-026784.md) | [8.6](/filings/0001437749-25-038435.md) | [9.8](/filings/0001437749-25-003752.md) | [10.3](/filings/0001437749-25-017178.md) | [3.8](/filings/0001437749-25-026930.md) | [3.2](/filings/0001437749-26-027665.md) | [2.8](/filings/0001437749-26-004343.md) | [3.0](/filings/0001437749-26-017042.md) | [4.9](/filings/0001437749-26-027665.md) | | Long-term debt | $m | [0.0](/filings/0001437749-24-003902.md) | [0.0](/filings/0001437749-24-003902.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [9.0](/filings/0001437749-25-038435.md) | [7.0](/filings/0001437749-25-026930.md) | [3.1](/filings/0001437749-25-026930.md) | [3.0](/filings/0001437749-25-026930.md) | [2.0](/filings/0001437749-26-027665.md) | [1.8](/filings/0001437749-26-004343.md) | [0.7](/filings/0001437749-26-017042.md) | [6.1](/filings/0001437749-26-027665.md) | [7.2](/filings/0001437749-26-027665.md) | [9.0](/filings/0001437749-26-004343.md) | [9.3](/filings/0001437749-26-017042.md) | [8.2](/filings/0001437749-26-027665.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(264) d](/filings/0001437749-24-037840.md) | [(106)](/filings/0001437749-24-003902.md) | [(704) d](/filings/0001437749-25-017178.md) | [290 d](/filings/0001437749-25-026930.md) | [167 d](/filings/0001437749-25-038435.md) | [(318)](/filings/0001437749-26-004343.md) | [(189) d](/filings/0001437749-26-017042.md) | [(704) d](/filings/0001437749-26-027665.md) | [(241) d](/filings/0001437749-25-038435.md) | [(812)](/filings/0001437749-26-004343.md) | [(723) d](/filings/0001437749-26-017042.md) | [(442) d](/filings/0001437749-26-027665.md) | | Capital expenditure | $k | [120 d](/filings/0001437749-24-037840.md) | [185](/filings/0001437749-25-003752.md) | [(4.6) d](/filings/0001437749-25-017178.md) | [0.0 d](/filings/0001437749-25-026930.md) | [10.0 d](/filings/0001437749-25-038435.md) | [164](/filings/0001437749-26-004343.md) | [15.5 d](/filings/0001437749-26-017042.md) | [1.5 d](/filings/0001437749-26-027665.md) | [2.8 d](/filings/0001437749-25-038435.md) | [165](/filings/0001437749-26-004343.md) | [5.7 d](/filings/0001437749-26-017042.md) | [18.1 d](/filings/0001437749-26-027665.md) | | Dividends paid | $k | not reported | [1,001](/filings/0001437749-25-003752.md) | [1,001](/filings/0001437749-25-017178.md) | not reported | not reported | [1,007](/filings/0001437749-25-003752.md) | [1,001](/filings/0001437749-25-017178.md) | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends ## Shares | Line item | Unit | Q2 FY2020 (2020-03-31) | Q3 FY2020 (2020-06-30) | Q1 FY2021 (2020-12-31) | Q2 FY2021 (2021-03-31) | Q3 FY2021 (2021-06-30) | Q1 FY2022 (2021-12-31) | Q2 FY2022 (2022-03-31) | Q3 FY2022 (2022-06-30) | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q2 FY2024 (2024-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [37.3](/filings/0001654954-21-005506.md) | [52.2](/filings/0001654954-21-008840.md) | [52.1](/filings/0001654954-22-001424.md) | [53.5](/filings/0001654954-22-006755.md) | [61.4](/filings/0001437749-22-020140.md) | [57.8](/filings/0001437749-23-003144.md) | [1.3](/filings/0001437749-23-014599.md) | [1.3](/filings/0001437749-23-023130.md) | [60.4](/filings/0001437749-23-003144.md) | [1.3](/filings/0001437749-24-017042.md) | [2.4](/filings/0001437749-23-023130.md) | [3.0](/filings/0001437749-24-017042.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 11,205,045 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027665.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.